MycoBiomDB – Record Details (MyCo_5601)

Biomarker Record Details

Database ID: MyCo_5601
DB IDMyCo_5601
TitleProspective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis
Year2016
PMID26400571
Fungal Diseases involvedInvasive aspergillosis
Associated Medical ConditionHaematopoietic stem cell transplantation or chemotherapy for acute leukaemia
GenusAspergillus
Speciesspp.
OrganismAspergillus spp.
Ethical StatementThe study was approved by the local ethics committees of the MUI (Ethikommission der Medizinischen Universität Innsbruck, UN4529). UKW and HEL tested their samples as part of routine diagnostic care.
Site of InfectionNone
Opportunistic invasiveInvasive
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameITS
Biomarker Full NameInternal Transcribed Spacer
Biomarker TypeDiagnostic
BiomoleculeGene
Geographical LocationAustria
CohortOver a period of 2 years, twice-weekly serum samples were taken from allogeneic haematopoietic stem cell transplant re- cipients and patients receiving myelosuppressive chemotherapy during hospitalization and admitted to the Department for In- ternal Medicine II, University Hospital Würzburg (UKW), Germany, Internal Medicine V, University Hospital Innsbruck, and Internal Medicine, Hospital Elisabethinen, Linz (HEL), Austria. wo thousand one hundred and twenty-eight sera from 213 patients were investigated and strati ed according to the revised European Organization for the Research and Treatment of Cancer/Mycoses Study Group criteria for invasive fungal disease.
Cohort No.213
Age GroupNone
P ValueNone
Sensitivity0.714
Specificity0.923
Positive Predictive Value0.625
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismNone
TechniquePCR
Analysis MethodqRT-PCR
ELISA kitsNone
Assay DataNone
Validation Techniques usedqRT-PCR
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone